Fumaric acid ester versus fumaric acid esters plus narrow band UVB in patients with severe plaque psoriasis
- Conditions
- Severe Plaque PsoriasisMedDRA version: 12.1Level: LLTClassification code 10050576Term: Psoriasis vulgaris
- Registration Number
- EUCTR2010-019151-22-AT
- Lead Sponsor
- Medizinische Universität Wien, Univ.Klinik f.Dermatologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patient with moderately severe to severe Psoriasis (BSA = 10 and PASI = 10)
Age between 18 and 80 years
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
pregnant woman and satisfying women
cancer, chronic infections, autoimmune diseases
gastrointestinal illnesses
liver disease
renal malfunctions
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method